Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Helyezés a részvények között #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Részvényárfolyam
$0.2488447
Utolsó szinkronizálás: 2024-10-01
Piaci kapitalizáció
$2.01M
Változás (1 nap)
-1.88%
Változás (1 év)
0.00%
Ország
IN
Kereskedés Ortin Laboratories Limited (ORTINLAB)

Kategória

Bevétel a(z) Ortin Laboratories Limited (ORTINLAB) részvényhez
Bevétel ekkor: Jun 2024 TTM: $89.95K
Ortin Laboratories Limited legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $89.95K. 2023 évben a vállalat $732.57K árbevételt ért el, amely csökkenés a 2022 évben elért $1.08M árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Ortin Laboratories Limited bevételtörténete 2008 és 2026 között
Bevétel az év végén
Év Bevétel Változtassa meg
2026 (TTM) $89.95K -64.48%
2024 $253.23K -65.43%
2023 $732.57K -32.44%
2022 $1.08M -2.82%
2021 $1.12M -95.72%
2020 $26.04M 10.75%
2019 $23.51M 92.06%
2018 $12.24M 87.73%
2017 $6.52M 8.62%
2016 $6.00M -4.55%
2015 $6.29M -33.47%
2014 $9.45M -12.98%
2013 $10.86M -35.79%
2012 $16.92M 20.37%
2011 $14.06M 101.43%
2010 $6.98M 19.15%
2009 $5.86M -19.40%
2008 $7.27M 0.00%
Hasonló cégek vagy versenytársak bevétele